ntcb01
mAbexperimentalADC
Clinical trial activity
1 trials · 1 clinical orgs · 0 marketing orgs
Phase 1
0
Phase 2
1
Phase 3
1
Phase 4
0
Earliest trial started Dec 27, 2024 (NCT06625931)
Timeline
2020s
- Jan 1, 2024
Earliest Phase 3 Sponsor(trial)
Indications
Studied for
Mechanism of action
- Nectin-4INHIBITOR
NECTIN4 inhibitor
Chemistry & pharmacology
- Payload
- mmae
Oral
No
Parenteral
No
Topical
No
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT06625931 | Phase 3 | Dec 27, 2024 | Yuhan Pharmaceutical Company |
Showing 1 of 1 trials
Page 1 / 1
Organizations
Research & Development (1)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Yuhan Pharmaceutical Company | For profit | 1 | 1 | 1 | 2024 |
1 organizations
Page 1 / 1